Use of low dose IL-2 for treating autoimmune-related or inflammatory disorders

• 收藏
• 分享

专利权人:

INSERM (Institut National de la Sante et de la Recherche Medicale;Sorbonne Universite;Assistance Publique - Hopitaux de Paris

发明人:

KLATZMANN, David,SAADOUN, David,CACOUB, Patrice,PIAGGIO, Eliane,BENSIMON, Gilbert,BERNARD, Claude,ROSENZWAJG, Michele

申请号：

AU2020204023

公开号：

AU2020204023A1

申请日:

2020.06.17

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

#$%^&*AU2020204023A120200709.pdf#####C: Interwovn NRPortbl DCC AAR 17360589 l.docx-l7072018 ABSTRACT The present invention relates to novel therapies for treating autoimmune and inflammatory diseases. More specifically, the present invention relates to a use of low dose interleukin-2 for the treatment of type I diabetes and other autoimmune and/or inflammatory diseases.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/